What is MariMed?
Established in 2011 and headquartered in Massachusetts, MariMed operates as a comprehensive management service provider for the cannabis industry. The company's core business involves the design, development, financing, and optimization of medical cannabis cultivation, production, and dispensary facilities. This integrated approach allows MariMed to manage the entire lifecycle of cannabis operations, from cultivation to retail, positioning it as a key player in a highly regulated and rapidly evolving market. The company's business model is centered on providing expertise and capital for facility development and operational efficiency.
How much funding has MariMed raised?
MariMed has raised a total of $85M across 3 funding rounds:
Debt
$4M
Share Placement
$46M
Debt
$35M
Debt (2017): $4M, investors not publicly disclosed
Share Placement (2021): $46M led by Hadron
Debt (2023): $35M supported by Chicago Atlantic Group
Key Investors in MariMed
Hadron
Hadron is an entity that participated in a share placement, indicating a strategic investment in MariMed's growth and operational expansion.
Chicago Atlantic Group
Chicago Atlantic Group is a credit and equity-focused investing platform that targets complex market opportunities, suggesting their involvement in MariMed's debt financing aligns with their strategy of deploying capital across specialized sectors.
What's next for MariMed?
The recent major strategic investment signifies MariMed's ongoing growth phase and its commitment to expanding its multi-state footprint. This infusion of capital is likely to be directed towards enhancing its cultivation and production capabilities, optimizing existing dispensary facilities, and potentially exploring new market entries. As a management service provider, MariMed's strategic investments will enable it to further refine its operational models and solidify its position as a leader in cannabis facility management and development. The company's focus on financing and optimizing facilities suggests a strategy aimed at long-term value creation and market share expansion.
See full MariMed company page
